Opthalmologic Outcomes-Raloxifene trials

Trial NameNLength of Treatment (years)Length of FU (years)PlaceboR 60R 120RR95% CINotes
PlaceboR60R120No.RateNo.RateNo.Rate
MORE
Grady, 200439:
Cataracts
257651293.31602910.90.8–1.1Self report
Cataracts surgery3.38616310.7–1.2
CORE
RUTH
Barrett-Connor, 200646
Cataracts
505750445.639113.9137413.340.960.83–1.11P = 0.56
Unsolicited Self report

From: Appendix D, Evidence Tables

Cover of Comparative Effectiveness of Medications To Reduce Risk of Primary Breast Cancer in Women
Comparative Effectiveness of Medications To Reduce Risk of Primary Breast Cancer in Women [Internet].
AHRQ Comparative Effectiveness Reviews, No. 17.
Nelson HD, Fu R, Humphrey L, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.